Glyset

Active Ingredient(s): Miglitol
FDA Approved: * December 18, 1996
Pharm Company: * PHARMACIA AND UPJOHN
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Glyset Overview

Miglitol is an oral anti-diabetic drug that acts by inhibiting the ability of the patient to break down complex carbohydrates into glucose. It is primarily used in diabetes mellitus type 2 for establishing greater glycemic control by preventing the digestion of carbohydrates (such as disaccharides, oligosaccharides, and polysaccharides) into monosaccharides which can be absorbed by the body.[1] Miglitol, and other structurally-related iminosugars, inhibit glycoside hydrolase e...

Read more Glyset Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Miglitol

Recent Glyset Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Miglitol
  • Tablet: 100mg, 25mg, 50mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Glyset: (3 results)

Sorted by National Drug Code
  • 0009-5012 Glyset 25 mg Oral Tablet by Pharmacia and Upjohn Company
  • 0009-5013 Glyset 50 mg Oral Tablet by Pharmacia and Upjohn Company
  • 0009-5014 Glyset 100 mg Oral Tablet by Pharmacia and Upjohn Company

Other drugs which contain Miglitol or a similar ingredient: (1 result)

Related Glyset Topics:

glyset
miglitol for diabetes from drug group alpha gulucosidose inhibitors...






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 17 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA